Although TRAIL has previously been implicated in tumor immune surveillance [133,152,153], TRAIL has been shown to induce PD-L1 expression and promote the epithelial–mesenchymal transition in the squamous cell carcinoma of the esophagus [154]. Here, TNFSF10 is linked to neoplasm.